Abstract
Synthesis and characterization of (R)-N(alpha)-(2,2-diphenylacetyl)-N-(4-hydroxybenzyl)-N(omega)-([2,3-(3)H]-propanoyl)argininamide ([(3)H]-UR-MK114), an easily accessible tritium-labeled NPY Y(1) receptor (Y(1)R) antagonist (K(B): 0.8 nM, calcium assay, HEL cells) derived from the (R)-argininamide BIBP 3226, is reported. The radioligand binds with high affinity (K(D), saturation: 1.2 nM, kinetic experiments: 1.1 nM, SK-N-MC cells) and selectivity for Y(1)R over Y(2), Y(4), and Y(5) receptors. The title compound is a useful pharmacological tool for the determination of Y(1)R ligand affinities, quantification of Y(1)R binding sites, and autoradiography.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Arginine / analogs & derivatives*
-
Arginine / chemical synthesis
-
Arginine / chemistry
-
Arginine / pharmacology
-
Binding Sites
-
CHO Cells
-
Cell Line, Tumor
-
Chemistry, Pharmaceutical / methods*
-
Chromatography, High Pressure Liquid
-
Cricetinae
-
Cricetulus
-
Drug Design
-
Guanidine / chemistry*
-
Humans
-
Kinetics
-
Receptors, Neuropeptide Y / antagonists & inhibitors*
-
Receptors, Neuropeptide Y / chemistry
-
Tritium / chemistry*
Substances
-
Nalpha-(2,2-diphenylacetyl)-N-(4-hydroxybenzyl)-Nomega-propanoylargininamide
-
Receptors, Neuropeptide Y
-
neuropeptide Y-Y1 receptor
-
Tritium
-
argininamide
-
Arginine
-
Guanidine